Koenraad De Geest

Professor

  • 7222 Citations
  • 42 h-Index
1984 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 7222 Citations
  • 42 h-Index
  • 91 Article
  • 3 Review article
  • 1 Comment/debate
Filter
Article
Article
18 Scopus citations

A bleomycin/ifosfamide/cisplatin regimen exhibits poor activity against persistent or recurrent squamous gynecologic cancers

Behbakht, K., Massad, L. S., Yordan, E. L., Lincoln, S. H., Eriksson, J. A. H., Winkelman, L., DeGeest, K., Kirschner, C. & Wilbanks, G. D., Feb 7 1996, In : European Journal of Gynaecological Oncology. 17, 1, p. 7-12 6 p.

Research output: Contribution to journalArticle

5 Scopus citations

Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: A Gynecologic Oncology Group trial

Matei, D., Sill, M. W., Lankes, H. A., DeGeest, K., Bristow, R. E., Mutch, D., Yamada, S. D., Cohn, D., Calvert, V., Farley, J., Petricoin, E. F. & Birrer, M. J., Jan 1 2011, In : Journal of Clinical Oncology. 29, 1, p. 69-75 7 p.

Research output: Contribution to journalArticle

139 Scopus citations

Adenosarcoma in a patient with vaginal endometriosis

Anderson, J., Behbakht, K., De Geest, K. & Bitterman, P., Nov 2001, In : Obstetrics and gynecology. 98, 5, p. 964-966 3 p.

Research output: Contribution to journalArticle

19 Scopus citations

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W., Carroll, A. R., Spannuth, W. A., Deavers, M. T., Allen, J. K., Han, L. Y., Kamat, A. A., Shahzad, M. M. K., McIntyre, B. W., Diaz-Montero, C. M., Jennings, N. B., Lin, Y. G., Merritt, W. M., DeGeest, K., Vivas-Mejia, P. E. & 4 others, Lopez-Berestein, G., Schaller, M. D., Cole, S. W. & Lutgendorf, S. K., May 3 2010, In : Journal of Clinical Investigation. 120, 5, p. 1515-1523 9 p.

Research output: Contribution to journalArticle

164 Scopus citations

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies

Usha, L., Sill, M. W., Darcy, K. M., Benbrook, D. M., Hurteau, J. A., Michelin, D. P., Mannel, R. S., Hanjani, P., De Geest, K. & Godwin, A. K., Jun 1 2011, In : Gynecologic oncology. 121, 3, p. 455-461 7 p.

Research output: Contribution to journalArticle

36 Scopus citations

All-trans-retinoic acid inhibits the proliferation of cell lines derived from human cervical neoplasia

Behbakht, K., Degeest, K., Turyk, M. E. & Wilbanks, G. D., Apr 1996, In : Gynecologic oncology. 61, 1, p. 31-39 9 p.

Research output: Contribution to journalArticle

14 Scopus citations

A patient with multiple, malignant melanomas of the lower genital tract

Podczaski, E., Abt, A., Kaminski, P., Larson, J., Sorosky, J., DeGeest, K. & Mortel, R., Jun 1990, In : Gynecologic oncology. 37, 3, p. 422-426 5 p.

Research output: Contribution to journalArticle

18 Scopus citations

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

Aghajanian, C., Blessing, J. A., Darcy, K. M., Reid, G., DeGeest, K., Rubin, S. C., Mannel, R. S., Rotmensch, J., Schilder, R. J. & Riordan, W., Nov 1 2009, In : Gynecologic oncology. 115, 2, p. 215-220 6 p.

Research output: Contribution to journalArticle

43 Scopus citations

A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gold, M. A., Brady, W. E., Lankes, H. A., Rose, P. G., Kelley, J. L., De Geest, K., Crispens, M. A., Resnick, K. E. & Howell, S. B., Jun 2012, In : Gynecologic oncology. 125, 3, p. 635-639 5 p.

Research output: Contribution to journalArticle

23 Scopus citations

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: A Gynecologic Oncology Group study

Rose, P. G., Blessing, J. A., Ball, H. G., Hoffman, J., Warshal, D., DeGeest, K. & Moore, D. H., Feb 1 2003, In : Gynecologic oncology. 88, 2, p. 130-135 6 p.

Research output: Contribution to journalArticle

132 Scopus citations

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

Herzog, T. J., Sill, M. W., Walker, J. L., O'Malley, D., Shahin, M., Degeest, K., Weiner, S. A., Mutch, D., Debernardo, R. L. & Lentz, S. S., Mar 2011, In : Gynecologic oncology. 120, 3, p. 454-458 5 p.

Research output: Contribution to journalArticle

23 Scopus citations

A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: A gynecologic oncology group study

Plaxe, S. C., Blessing, J. A., Olt, G., Husseinzadah, N., Lentz, S. S., DeGeest, K. & Valea, F. A., Sep 12 2002, In : Cancer Chemotherapy and Pharmacology. 50, 2, p. 151-154 4 p.

Research output: Contribution to journalArticle

7 Scopus citations
35 Scopus citations

A phase i study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

Morgan, M. A., Sill, M. W., Fujiwara, K., Greer, B., Rubin, S. C., Degeest, K., Yamada, S. D., Waggoner, S., Coleman, R. L., Walker, J. L. & Mannel, R. S., May 1 2011, In : Gynecologic oncology. 121, 2, p. 264-268 5 p.

Research output: Contribution to journalArticle

15 Scopus citations

A phase i trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study

Moore, K. N., Sill, M. W., Miller, D. S., McCourt, C., De Geest, K., Rose, P. G., Cardenes, H. R., Mannel, R. S., Farley, J. H., Schilder, R. J. & Fracasso, P. M., Dec 2012, In : Gynecologic oncology. 127, 3, p. 456-461 6 p.

Research output: Contribution to journalArticle

30 Scopus citations

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Homesley, H. D., Filiaci, V., Gibbons, S. K., Long, H. J., Cella, D., Spirtos, N. M., Morris, R. T., DeGeest, K., Lee, R. & Montag, A., Mar 2009, In : Gynecologic oncology. 112, 3, p. 543-552 10 p.

Research output: Contribution to journalArticle

147 Scopus citations

A randomized phase III trial of IV carboplatin and paclitaxel x 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study

Mannel, R. S., Brady, M. F., Kohn, E. C., Hanjani, P., Hiura, M., Lee, R., DeGeest, K., Cohn, D. E., Monk, B. J. & Michael, H., Jul 2011, In : Gynecologic oncology. 122, 1, p. 89-94 6 p.

Research output: Contribution to journalArticle

47 Scopus citations

A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival

Shamshirsaz, A. A., Buekers, T., DeGeest, K., Bender, D., Zamba, G. & Goodheart, M. J., Oct 1 2011, In : International Journal of Gynecological Cancer. 21, 7, p. 1232-1240 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Assessment of pretreatment laparotomy in patients with cervical carcinoma prior to radiotherapy

Podczaski, E. S., Palombo, C., Manetta, A., Larson, J., DeGeest, K., Mortel, R. & Andrews, C., Apr 1989, In : Gynecologic oncology. 33, 1, p. 71-75 5 p.

Research output: Contribution to journalArticle

33 Scopus citations

Biobehavioral and neuroendocrine correlates of antioxidant enzyme activity in ovarian carcinoma

Bayer, J. L., Spitz, D. R., Christensen, D., McCormick, M. L., Farley, D., DeGeest, K., Damoush, L., Aust, S., Sood, A. K. & Lutgendorf, S. K., Nov 1 2015, In : Brain, Behavior, and Immunity. 50, p. 58-62 5 p.

Research output: Contribution to journalArticle

4 Scopus citations

Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma

Lutgendorf, S. K., Lamkin, D. M., Jennings, N. B., Arevalo, J. M. G., Penedo, F., DeGeest, K., Langley, R. R., Lucci, J. A., Cole, S. W., Lubaroff, D. M. & Sood, A. K., Nov 1 2008, In : Clinical Cancer Research. 14, 21, p. 6839-6846 8 p.

Research output: Contribution to journalArticle

99 Scopus citations

BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: A gynecologic oncology group study

Smith, S. A., Richards, W. E., Caito, K., Hanjani, P., Markman, M., DeGeest, K. & Gallion, H. H., Jan 1 2001, In : Gynecologic oncology. 83, 3, p. 586-592 7 p.

Research output: Contribution to journalArticle

19 Scopus citations

Cisplatin as initial chemotherapy in ovarian carcinosarcomas: A Gynecologic Oncology Group study

Thigpen, J. T., Blessing, J. A., DeGeest, K., Look, K. Y. & Homesley, H. D., May 1 2004, In : Gynecologic oncology. 93, 2, p. 336-339 4 p.

Research output: Contribution to journalArticle

58 Scopus citations

Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disability

Schrepf, A., Clevenger, L., Christensen, D., DeGeest, K., Bender, D., Ahmed, A., Goodheart, M. J., Dahmoush, L., Penedo, F., Lucci, J. A., Ganjei-Azar, P., Mendez, L., Markon, K., Lubaroff, D. M., Thaker, P. H., Slavich, G. M., Sood, A. K. & Lutgendorf, S. K., Mar 15 2013, In : Brain, Behavior, and Immunity. 30, SUPPL., p. S126-S134

Research output: Contribution to journalArticle

57 Scopus citations

Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients

Lutgendorf, S. K., Lamkin, D. M., DeGeest, K., Anderson, B., Dao, M., McGinn, S., Zimmerman, B., Maiseri, H., Sood, A. K. & Lubaroff, D. M., Aug 2008, In : Brain, Behavior, and Immunity. 22, 6, p. 890-900 11 p.

Research output: Contribution to journalArticle

48 Scopus citations

Depression, social support, and beta-adrenergic transcription control in human ovarian cancer

Lutgendorf, S. K., DeGeest, K., Sung, C. Y., Arevalo, J. M., Penedo, F., Lucci, J., Goodheart, M., Lubaroff, D., Farley, D. M., Sood, A. K. & Cole, S. W., Feb 2009, In : Brain, Behavior, and Immunity. 23, 2, p. 176-183 8 p.

Research output: Contribution to journalArticle

113 Scopus citations

Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-β1

De Geest, K., Bergman, C. A., Turyk, M. E., Frank, B. S. & Wilbanks, G. D., Dec 1994, In : Gynecologic oncology. 55, 3, p. 376-385 10 p.

Research output: Contribution to journalArticle

28 Scopus citations
2 Scopus citations

Diurnal cortisol and survival in epithelial ovarian cancer

Schrepf, A., Thaker, P. H., Goodheart, M. J., Bender, D., Slavich, G. M., Dahmoush, L., Penedo, F., DeGeest, K., Mendez, L., Lubaroff, D. M., Cole, S. W., Sood, A. K. & Lutgendorf, S. K., Mar 1 2015, In : Psychoneuroendocrinology. 53, p. 256-267 12 p.

Research output: Contribution to journalArticle

47 Scopus citations

Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer

Weinrib, A. Z., Sephton, S. E., DeGeest, K., Penedo, F., Bender, D., Zimmerman, B., Kirschbaum, C., Sood, A. K., Lubaroff, D. M. & Lutgendorf, S. K., Sep 15 2010, In : Cancer. 116, 18, p. 4410-4419 10 p.

Research output: Contribution to journalArticle

65 Scopus citations

Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group

Monk, B. J., Sill, M. W., Hanjani, P., Edwards, R., Rotmensch, J., De Geest, K., Bonebrake, A. J. & Walker, J. L., Mar 1 2011, In : Gynecologic oncology. 120, 3, p. 459-463 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth

Merritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S., Kamat, A. A., Han, L. Y., Landen, C. N., Jennings, N., De Geest, K., Langley, R. R., Villares, G., Sanguino, A., Lutgendorf, S. K., Lopez-Berestein, G., Bar-Eli, M. M. & Sood, A. K., Mar 2008, In : Journal of the National Cancer Institute. 100, 5, p. 359-372 14 p.

Research output: Contribution to journalArticle

198 Scopus citations

Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Brown, J., Brady, W. E., Schink, J., Van Le, L., Leitao, M., Yamada, S. D., De Geest, K. & Gershenson, D. M., Feb 1 2014, In : Cancer. 120, 3, p. 344-351 8 p.

Research output: Contribution to journalArticle

40 Scopus citations

Endocervical prostaglandin E2 gel for preinduction cervical softening

Thiery, M., Decoster, J. M., Parewijck, W., Noah, M. L., Derom, R., Van Kets, H., Defoort, P., Aertsens, W., Debruyne, G., De Geest, K. & Vandekerckhove, F., Mar 1984, In : Prostaglandins. 27, 3, p. 429-439 11 p.

Research output: Contribution to journalArticle

30 Scopus citations

Epigenetic regulation of maspin expression in human ovarian carcinoma cells

Rose, S. L., Fitzgerald, M. P., White, N. O., Hitchler, M. J., Futscher, B. W., De Geest, K. & Domann, F. E., Aug 1 2006, In : Gynecologic oncology. 102, 2, p. 319-324 6 p.

Research output: Contribution to journalArticle

48 Scopus citations

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: A phase III trial of the gynecologic cancer intergroup

Bookman, M. A., Brady, M. F., McGuire, W. P., Harper, P. G., Alberts, D. S., Friedlander, M., Colombo, N., Fowler, J. M., Argenta, P. A., De Geest, K., Mutch, D. G., Burger, R. A., Swart, A. M., Trimble, E. L., Accario-Winslow, C. & Roth, L. M., Mar 20 2009, In : Journal of Clinical Oncology. 27, 9, p. 1419-1425 7 p.

Research output: Contribution to journalArticle

502 Scopus citations

Expression of α-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine

Galili, U., Chen, Z. C. & DeGeest, K., Jul 2003, In : Gynecologic oncology. 90, 1, p. 100-108 9 p.

Research output: Contribution to journalArticle

19 Scopus citations

Extended‐field radiation therapy for carcinoma of the cervix

Podczaski, E., Stryker, J. A., Kaminski, P., Ndubisi, B., Larson, J., Degeest, K., Sorosky, J. & Mortel, R., Jul 15 1990, In : Cancer. 66, 2, p. 251-258 8 p.

Research output: Contribution to journalArticle

53 Scopus citations

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study

Hensley, M. L., Blessing, J. A., DeGeest, K., Abulafia, O., Rose, P. G. & Homesley, H. D., Jun 2008, In : Gynecologic oncology. 109, 3, p. 323-328 6 p.

Research output: Contribution to journalArticle

181 Scopus citations

Focal adhesion kinase: An alternative focus for anti-angiogenesis therapy in ovarian cancer

Stone, R. L., Baggerly, K. A., Armaiz-Pena, G. N., Kang, Y., Sanguino, A. M., Thanapprapasr, D., Dalton, H. J., Bottsford-Miller, J., Zand, B., Akbani, R., Diao, L., Nick, A. M., DeGeest, K., Lopez-Berestein, G., Coleman, R. L., Lutgendorf, S. & Sood, A. K., Jul 2014, In : Cancer Biology and Therapy. 15, 7, p. 919-929 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

Glucose as a prognostic factor in ovarian carcinoma

Lamkin, D. M., Spitz, D. R., Shahzad, M. M. K., Zimmerman, B., Lenihan, D. J., Degeest, K., Lubaroff, D. M., Shinn, E. H., Sood, A. K. & Lutgendorf, S. K., Mar 1 2009, In : Cancer. 115, 5, p. 1021-1027 7 p.

Research output: Contribution to journalArticle

37 Scopus citations

Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines

De Geest, K., Turyk, M. E., Hosken, M. I., Hudson, J. B., Laimins, L. A. & Wilbanks, G. D., Jun 1993, In : Gynecologic oncology. 49, 3, p. 303-310 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

HLA class i antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

Han, L., Fletcher, M. S., Urbauer, D. L., Mueller, P., Landen, C. N., Kamat, A. A., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Deavers, M. T., De Geest, K., Gershenson, D. M., Lutgendorf, S. K., Ferrone, S. & Sood, A. K., Jun 1 2008, In : Clinical Cancer Research. 14, 11, p. 3372-3379 8 p.

Research output: Contribution to journalArticle

102 Scopus citations

Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: A non-randomized comparison using an explanatory analysis: A Gynecologic Oncology Group study

Greer, B. E., Bundy, B. N., Ozols, R. F., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R., DeGeest, K., Hartenbach, E. M., Baergen, R. N. & Copeland, L. J., Oct 1 2005, In : Gynecologic oncology. 99, 1, p. 71-79 9 p.

Research output: Contribution to journalArticle

46 Scopus citations

Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients

Lutgendorf, S. K., Weinrib, A. Z., Penedo, F., Russell, D., DeGeest, K., Costanzo, E. S., Henderson, P. J., Sephton, S. E., Rohleder, N., Lucci, J. A., Cole, S., Sood, A. K. & Lubaroff, D. M., Oct 10 2008, In : Journal of Clinical Oncology. 26, 29, p. 4820-4827 8 p.

Research output: Contribution to journalArticle

119 Scopus citations

Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: Long-term follow-up of a prospective trial

Engle, D. B., Connor, J. P., Morris, P. C., Bender, D. P., De Geest, K., Ahmed, A. & Goodheart, M. J., Sep 1 2012, In : Archives of Gynecology and Obstetrics. 286, 3, p. 717-721 5 p.

Research output: Contribution to journalArticle

7 Scopus citations

Intraperitoneal interferon-α in residual ovarian carcinoma: A phase II gynecologic oncology group study

Berek, J. S., Markman, M., Stonebraker, B., Lentz, S. S., Adelson, M. D., DeGeest, K. & Moore, D., Oct 1999, In : Gynecologic oncology. 75, 1, p. 10-14 5 p.

Research output: Contribution to journalArticle

53 Scopus citations

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173

Coleman, R. L., Ali, S., Levenback, C. F., Gold, M. A., Fowler, J. M., Judson, P. L., Bell, M. C., De Geest, K., Spirtos, N. M., Potkul, R. K., Leitao, M. M., Bakkum-Gamez, J. N., Rossi, E. C., Lentz, S. S., Burke, J. J., Van Le, L. & Trimble, C. L., Feb 2013, In : Gynecologic oncology. 128, 2, p. 155-159 5 p.

Research output: Contribution to journalArticle

42 Scopus citations

Isolated vaginal recurrences of endometrial carcinoma

Morgan, J. D., Reddy, S., Sarin, P., Yordan, E., DeGeest, K. & Hendrickson, F. R., Nov 1993, In : RADIOLOGY. 189, 2, p. 609-613 5 p.

Research output: Contribution to journalArticle

32 Scopus citations